rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Barry Canton

10% owner

Company insider

Files Form 4 as: 10% owner, Ginkgo Bioworks Holdings.

Every Form 4 they filed

In numbers

Trades disclosed
295
Buys
0
Sells
167
Bought
$0
Sold
$61.7M
Companies
1
Companies where not an officer
1
First trade
1 Oct 2021
Last trade
28 Jul 2026
Last filed
30 Jul 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
DNA Ginkgo Bioworks Holdings10% owner · Biotechnology · last 28 Jul 20260 buys · 167 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
30Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
28 Jul 2026filed 30 Jul 2026DNA Ginkgo Bioworks Holdingsoption or derivative · BiotechnologySEC FORM 4 Code A—35,736filing
28 Jul 2026filed 30 Jul 2026DNA Ginkgo Bioworks Holdingsoption or derivative · BiotechnologySEC FORM 4 Code A—117,135filing
28 Jul 2026filed 30 Jul 2026DNA Ginkgo Bioworks Holdingsoption or derivative · BiotechnologySEC FORM 4 Code A—39,038filing
28 Jul 2026filed 30 Jul 2026DNA Ginkgo Bioworks Holdingsoption or derivative · BiotechnologySEC FORM 4 Code A—35,736filing
28 Jul 2026filed 30 Jul 2026DNA Ginkgo Bioworks Holdingsoption or derivative · BiotechnologySEC FORM 4 Code A—117,135filing
28 Jul 2026filed 30 Jul 2026DNA Ginkgo Bioworks Holdingsoption or derivative · BiotechnologySEC FORM 4 Code A—39,038filing
28 Jul 2026filed 30 Jul 2026DNA Ginkgo Bioworks Holdingsoption or derivative · BiotechnologySEC FORM 4 Code A—127,423filing
28 Jul 2026filed 30 Jul 2026DNA Ginkgo Bioworks Holdingsoption or derivative · BiotechnologySEC FORM 4 Code A—127,423filing
10 Apr 2026filed 13 Apr 2026DNA Ginkgo Bioworks HoldingsBiotechnologySEC FORM 4 Sold$802K124,727 at $6.43filing
10 Apr 2026filed 13 Apr 2026DNA Ginkgo Bioworks HoldingsBiotechnologySEC FORM 4 Sold$802K124,727 at $6.43filing
9 Apr 2026filed 13 Apr 2026DNA Ginkgo Bioworks HoldingsBiotechnologySEC FORM 4 Code M—251,786filing
9 Apr 2026filed 13 Apr 2026DNA Ginkgo Bioworks Holdingsoption or derivative · BiotechnologySEC FORM 4 Code M—251,786filing
9 Apr 2026filed 13 Apr 2026DNA Ginkgo Bioworks Holdingsoption or derivative · BiotechnologySEC FORM 4 Code M—251,786filing
9 Apr 2026filed 13 Apr 2026DNA Ginkgo Bioworks HoldingsBiotechnologySEC FORM 4 Code M—251,786filing
9 Apr 2026filed 10 Apr 2026DNA Ginkgo Bioworks HoldingsBiotechnologySEC FORM 4 Sold$84K13,116 at $6.40filing
9 Apr 2026filed 10 Apr 2026DNA Ginkgo Bioworks HoldingsBiotechnologySEC FORM 4 Sold$84K13,116 at $6.40filing
8 Apr 2026filed 10 Apr 2026DNA Ginkgo Bioworks HoldingsBiotechnologySEC FORM 4 Code M—27,738filing
8 Apr 2026filed 10 Apr 2026DNA Ginkgo Bioworks HoldingsBiotechnologySEC FORM 4 Sold$91K13,155 at $6.93filing
8 Apr 2026filed 10 Apr 2026DNA Ginkgo Bioworks Holdingsoption or derivative · BiotechnologySEC FORM 4 Code M—27,738filing
8 Apr 2026filed 10 Apr 2026DNA Ginkgo Bioworks Holdingsoption or derivative · BiotechnologySEC FORM 4 Code M—27,738filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Health Care167

Buys in green, sells in red, by the company’s sector.

Related people

Steven P. CoenOfficer · Insider at Ginkgo Bioworks Holdings, filing Form 4 there in the last year
Christian O. HenryDirector · Director at Ginkgo Bioworks Holdings, filing Form 4 there in the last year
Reshma P. ShettyDirector and Officer and 10% owner · Insider at Ginkgo Bioworks Holdings, filing Form 4 there in the last year
Jason R. KellyDirector and Officer · Insider at Ginkgo Bioworks Holdings, filing Form 4 there in the last year
Ross FubiniDirector · Director at Ginkgo Bioworks Holdings, filing Form 4 there in the last year